Ardelyx (ARDX) Interest Coverage Ratio (2013 - 2026)
Ardelyx (ARDX) posted Interest Coverage Ratio of 6.36 for Q1 2026, down 326.81% on a QoQ basis from 2.8 in Q4 2025, and up 26.65% year-over-year from 5.02 in Q1 2025.
Ardelyx (ARDX) Interest Coverage Ratio (2013 - 2026) Analysis & Trends
Ardelyx's Interest Coverage Ratio history runs 14 years deep, the most recent figure standing at 6.36 for Q1 2026.
- Quarterly Interest Coverage Ratio rose 26.65% year-over-year to 6.36 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 7.26 (down 202.95% YoY) and the FY2025 annual result came in at 0.19, down 39.25% from the prior year.
- Interest Coverage Ratio was 6.36 for Q1 2026 at Ardelyx, down from 2.8 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 58.95 in Q4 2022 and bottomed at 33.52 in Q2 2022.
- A 5-year average of 6.12 and a median of 8.67 in 2025 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio surged 264.44% — and 2023, when it sank 121.03%.
- Ardelyx's Interest Coverage Ratio stood at 58.95 in 2022, then sank by 121.03% to 12.39 in 2023, then jumped by 108.4% to 1.04 in 2024, then surged by 169.39% to 2.8 in 2025, then plunged by 326.81% to 6.36 in 2026.
- Business Quant data shows ARDX's Interest Coverage Ratio at 6.36 in Q1 2026, 2.8 in Q4 2025, and 2.13 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn | -6.36 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.36 |
| Dec 31, 2025 | 2.80 |
| Sep 30, 2025 | 2.13 |
| Jun 30, 2025 | -6.49 |
| Mar 31, 2025 | -8.67 |
| Dec 31, 2024 | 1.04 |
| Sep 30, 2024 | 0.67 |
| Jun 30, 2024 | -11.52 |
| Mar 31, 2024 | -11.78 |
| Dec 31, 2023 | -12.39 |
| Sep 30, 2023 | 6.61 |
| Jun 30, 2023 | -15.11 |
| Mar 31, 2023 | -23.74 |
| Dec 31, 2022 | 58.95 |
| Sep 30, 2022 | -20.41 |
| Jun 30, 2022 | -33.52 |
| Mar 31, 2022 | -26.28 |
| Dec 31, 2021 | -35.85 |
| Sep 30, 2021 | -34.73 |
| Jun 30, 2021 | -37.30 |